STAT3 and Hepatic fibrosis: As another example, STAT3 is involved in the development of liver fibrosis, and a study by Su et al. (18) found that sorafenib and its derivative SC-1 activated Src-homology protein tyrosine phosphatase (SHP-1) and inhibited STAT3, which may represent a new strategy for antifibrotic drug discovery.